Cargando…

The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data

BACKGROUND: The National Institute for Health and Care Excellence 2008 guidelines on the treatment and management of familial hypercholesterolaemia (FH) recommend that children with FH should be considered for statin treatment by the age of 10 years. The Paediatric FH Register was established in 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramaswami, Uma, Cooper, Jackie, Humphries, Steve E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339547/ https://www.ncbi.nlm.nih.gov/pubmed/26948823 http://dx.doi.org/10.1136/archdischild-2015-308570

Ejemplares similares

The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
por: Humphries, Steve E., et al.
Publicado: (2018)

Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK
por: Kerr, Marion, et al.
Publicado: (2017)

Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
por: Humphries, Steve E., et al.
Publicado: (2019)

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register
por: Humphries, S.E., et al.
Publicado: (2018)

Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Cardiovascular risk stratification in familial hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2016)

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records
por: Iyen, Barbara, et al.
Publicado: (2020)

Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Futema, Marta, et al.
Publicado: (2017)

Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia
por: Pears, Robert, et al.
Publicado: (2015)

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study
por: Seed, Mary, et al.
Publicado: (2012)

Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries
por: Ramaswami, Uma, et al.
Publicado: (2020)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
por: Neil, Andrew, et al.
Publicado: (2008)

Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care
por: Jones, Matthew, et al.
Publicado: (2022)

Case-finding and genetic testing for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
por: Futema, Marta, et al.
Publicado: (2012)

Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia
por: Khamis, Amna, et al.
Publicado: (2015)

Real-World Outcomes with Lomitapide Use in Paediatric Patients with Homozygous Familial Hypercholesterolaemia
por: Ben-Omran, Tawfeg, et al.
Publicado: (2019)

Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse‐led clinics
por: Green, Peter, et al.
Publicado: (2015)

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic()
por: Futema, Marta, et al.
Publicado: (2013)

An online questionnaire survey of UK general practitioners’ knowledge and management of familial hypercholesterolaemia
por: Kwok, See, et al.
Publicado: (2016)

The UK National Screening Committee’s position on child–parent screening for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2021)

The genetics and screening of familial hypercholesterolaemia
por: Henderson, Raymond, et al.
Publicado: (2016)

Tendon xanthomas in familial hypercholesterolaemia
por: Bharath, Gopinath, et al.
Publicado: (2020)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Familial hypercholesterolaemia: cholesterol efflux and coronary disease
por: Versmissen, Jorie, et al.
Publicado: (2016)

LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
por: Gratton, Jasmine, et al.
Publicado: (2022)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
por: Cuchel, Marina, et al.
Publicado: (2014)

Management of homozygous familial hypercholesterolaemia in two brothers
por: Real, José, et al.
Publicado: (2018)

Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Dietary intervention for children and adolescents with familial hypercholesterolaemia
por: Capra, Maria Elena, et al.
Publicado: (2023)

Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing
por: Maglio, C, et al.
Publicado: (2014)

Integration of child–parent screening and cascade testing for familial hypercholesterolaemia
por: Wald, David S, et al.
Publicado: (2018)

Coronary artery calcium among patients with heterozygous familial hypercholesterolaemia
por: Tada, Hayato, et al.
Publicado: (2023)

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
por: Wiegman, Albert, et al.
Publicado: (2015)

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations
por: Futema, Marta, et al.
Publicado: (2014)

Familial Hypercholesterolaemia in the Malaysian Community: Prevalence, Under-Detection and Under-Treatment
por: Chua, Yung-An, et al.
Publicado: (2021)

A perspective for sequencing familial hypercholesterolaemia in African Americans
por: Wright, Michelle L, et al.
Publicado: (2016)

Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone
por: Diamond, David M, et al.
Publicado: (2021)

Hypercholesterolaemia in a vegan.
por: Duggan, B., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_3cip621g72b4grf3gs7il281gb